Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
1.
Neurochem Res ; 44(11): 2527-2535, 2019 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-31515677

RESUMO

Mas-related G-protein-coupled receptor subtype C (MrgC) has been shown to play an important role in the development of bone cancer pain. Ubiquitination is reported to participate in pain. However, whether MrgC ubiquitination plays a role in bone cancer pain remains unclear. To answer this question, we designed and performed this study. Osteosarcoma cells were implanted into the intramedullary space of the right femurs of C3H/HeJ mice to induce progressive bone cancer pain. MrgC agonist bovine adrenal medulla 8-22 (BAM 8-22) or MrgC antagonist anti-MrgC antibody were injected intrathecally on day 14 after bone cancer pain was successfully induced. The pain behaviors, the MrgC ubiquitination levels and intracellular calcium concentration in spinal neurons were measured before and after injection, respectively. With comparison to normal and sham group, mice in tumor group exhibited serious bone cancer pain on day 14, and the level of MrgC ubiquitination and intracellular calcium concentration in spinal neurons was significantly higher. Intrathecal injection of BAM 8-22 significantly alleviated bone cancer pain, increased the MrgC ubiquitination level and decreased intracellular calcium concentration in spinal neurons; however, these effects were reversed by administration of anti-MrgC antibody. Our study reveals that MrgC ubiquitination participates in the production and maintenance of bone cancer pain in mice, possibly through the regulation of intracellular calcium concentration in mice spinal neurons.


Assuntos
Neoplasias Ósseas/metabolismo , Cálcio/metabolismo , Dor do Câncer/metabolismo , Neurônios/metabolismo , Receptores Acoplados a Proteínas G/metabolismo , Medula Espinal/metabolismo , Analgésicos/uso terapêutico , Animais , Anticorpos/imunologia , Dor do Câncer/tratamento farmacológico , Linhagem Celular Tumoral , Masculino , Camundongos Endogâmicos C3H , Fragmentos de Peptídeos/uso terapêutico , Processamento de Proteína Pós-Traducional , Coelhos , Receptores Acoplados a Proteínas G/imunologia , Medula Espinal/citologia , Ubiquitinação
2.
Heliyon ; 8(12): e12430, 2022 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-36590502

RESUMO

Objective: To explore potential risk factors of postoperative nausea and vomiting (PONV) following ambulatory surgery. Method: Clinical data of 1670 cases receiving ambulatory surgery in Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School from September 2017 to December 2019 were retrospectively analyzed. They were categorized to PONV group and non-PONV group, and perioperative data in both groups were analyzed for assessing risk factors of PONV following ambulatory laparoscopy. Results: There were 156/1,670 (9.3%) PONV cases, and the female and male incidence in recruited cases was 12.0% and 6.0%, respectively. Analyses on perioperative data of them identified that female gender [adjusted odds ratio (aOR) = 2.060, P < 0.001], operation time >1 h (aOR = 1.554, P = 0.011), postoperative pain at rest (aOR = 1.909, P = 0.013) and postoperative pain during activities (aOR = 3.512, P < 0.001) were independent risk factors of PONV following ambulatory surgery. Furthermore, postoperative pain at rest and during activities were linearly, positively correlated to the incidence of PONV. Conclusion: Female gender, operation time >1 h and postoperative pain are closely related with the incidence of PONV following ambulatory surgery. Alleviating postoperative pain properly is one of the methods to reduce risk factors of PONV following ambulatory surgery.

3.
Fitoterapia ; 79(4): 314-6, 2008 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-18308482

RESUMO

A new cycloartane glycoside was isolated from the whole herbs of Camptosorus sibiricus. By means of spectroscopic methods its structure was established as 3beta, 7beta, 24beta, 25, 30-pentahydroxycycloartane-24, 30-di-O-beta-D-glucopyranoside (1). proflixian@163.com


Assuntos
Gleiquênias/química , Glicosídeos/química , Triterpenos/química , Antineoplásicos Fitogênicos/química , Antineoplásicos Fitogênicos/farmacologia , Linhagem Celular Tumoral , Humanos , Conformação Molecular
4.
Int J Cardiol ; 258: 68-73, 2018 05 01.
Artigo em Inglês | MEDLINE | ID: mdl-29429638

RESUMO

BACKGROUND: The association between intraoperative hypotension (IOH) and postoperative outcomes is not fully understood. We performed a meta-analysis to determine whether IOH is associated with increased risk of 30-day mortality, major adverse cardiac events (MACEs) and acute kidney injury (AKI) after non-cardiac surgery. METHODS: We searched PubMed and Embase through May 2016 to identify cohort studies that investigated the association between IOH and risk of 30-day mortality, MACEs, or AKI in adult patients after non-cardiac surgery. Ascertainment of IOH and assessment of outcomes were defined by the individual study. Considering the level of clinical heterogeneity, adjusted odds ratios (ORs) with 95% confidence interval (CIs) were pooled using a random-effects model. This meta-analysis is registered on PROSPERO (CRD42016049405). RESULTS: We included 14 cohort studies that were heterogeneous in terms of definition of IOH. IOH alone was associated with increased risk of 30-day mortality (OR 1.29 [95% CI, 1.19-1.41]), MACEs (OR 1.59 [95% CI, 1.23-2.05]), especially myocardial injury (OR 1.67 [95% CI, 1.31-2.13]), and AKI (OR 1.39 [95% CI, 1.09-1.77]). Triple low (IOH coincident with low bispectral index and low minimum alveolar concentration) also predicts increased risk of 30-day mortality (OR 1.32 [95% CI, 1.03-1.68]). CONCLUSIONS: IOH alone significantly increases the risk of postoperative 30-day mortality, MACEs, especially myocardial injury, and AKI in adult patients after non-cardiac surgery. Triple low also predicts increased risk of 30-day mortality after non-cardiac surgery. These findings provide evidence that IOH should be recognized as an independent risk factor for postoperative adverse outcomes after non-cardiac surgery.


Assuntos
Injúria Renal Aguda/mortalidade , Cardiopatias/mortalidade , Hipotensão/mortalidade , Complicações Intraoperatórias/mortalidade , Complicações Pós-Operatórias/mortalidade , Injúria Renal Aguda/diagnóstico , Injúria Renal Aguda/etiologia , Estudos de Coortes , Cardiopatias/diagnóstico , Cardiopatias/etiologia , Humanos , Hipotensão/complicações , Hipotensão/diagnóstico , Complicações Intraoperatórias/diagnóstico , Mortalidade/tendências , Complicações Pós-Operatórias/diagnóstico , Complicações Pós-Operatórias/etiologia , Fatores de Risco
5.
Arch Pharm Res ; 30(5): 653-8, 2007 May.
Artigo em Inglês | MEDLINE | ID: mdl-17615687

RESUMO

Nanoparticle realgar powders (NRP) inhibited U937 cell growth in a time and dose-dependent manner. U937 cells treated with NRP showed typical characteristics of apoptosis including the morphological changes and DNA fragmentation. Caspase family inhibitor (z-VAD-fmk), caspase-8, -9 inhibitor (z-IETD-fmk, Ac-LEHD-CHO, respectively) and caspase-3 inhibitor (z-DEVD-fmk) partially prevented NRP -induced apoptosis. Moreover, the classical substrates of caspase-3, poly-ADP ribose polymerase (PARP) was degraded after U937 cells treatment with NRP. In addition, NRP increased the ratio of Bax/Bcl-2 protein expression. Although p38 inhibitor (SB203580) and ERK inhibitor (PD98059) failed to block cell death, JNK inhibitor (SP600125) had marked inhibitory effects on NRP -induced apoptosis. Furthermore, the phosphorylation of JNK was up-regulated, suggesting that JNK was responsible for NRP -induced apoptosis in U937 cells. These results suggested that the caspase, mitochondria and MAPK signal pathways were involved in NRP-induced U937 apoptosis.


Assuntos
Apoptose/efeitos dos fármacos , Arsenicais/farmacologia , Caspases/fisiologia , Sistema de Sinalização das MAP Quinases/fisiologia , Mitocôndrias/fisiologia , Nanopartículas , Transdução de Sinais/fisiologia , Sulfetos/farmacologia , Fragmentação do DNA/efeitos dos fármacos , Relação Dose-Resposta a Droga , Humanos , Pós , Proteínas Proto-Oncogênicas c-bcl-2/fisiologia , Células U937 , Proteína X Associada a bcl-2/fisiologia
6.
Yao Xue Xue Bao ; 40(6): 533-5, 2005 Jun.
Artigo em Chinês | MEDLINE | ID: mdl-16144319

RESUMO

AIM: To study the chemical constituents of Sphaerophysa salsula (Pall.) DC. METHODS: Compounds were isolated by repeated chromatography, on silica gel and Sephadex LH-20 columns and identified by spectroscopic data (ESI-MS, 1H and 13C NMR, HSQC, HMBC). RESULTS: Eight compounds have been isolated and identified as: isorhamnetin-3-O-[6"-(3-hydroxy-3-methylglutaroyl)-beta-D-glucopyranoside] (I), quercitrin (II), n-butyl-O-beta-D-fructopyranoside (III), nicotinic acid (IV), succinic acid (V), erythrol (VI), D-mannitol (VII), uridine (VIII). CONCLUSION: Compound I is a new compound. Compounds I -VI were isolated from this genus for the first time.


Assuntos
Fabaceae/química , Flavonóis/isolamento & purificação , Glucosídeos/isolamento & purificação , Plantas Medicinais/química , Flavonóis/química , Glucosídeos/química , Conformação Molecular , Estrutura Molecular , Niacina/química , Niacina/isolamento & purificação , Raízes de Plantas/química , Caules de Planta/química , Quercetina/análogos & derivados , Quercetina/química , Quercetina/isolamento & purificação
8.
Nat Prod Res ; 22(15): 1379-83, 2008.
Artigo em Inglês | MEDLINE | ID: mdl-19023798

RESUMO

A new disaccharoside (2) together with a known disaccharose (1) was isolated from the ethanol extract of Camptosorus sibiricus Rupr. By means of chemical (hydrolysis) and spectroscopic methods (IR, 1D and 2D NMR, ESI-MS), the structures were established as beta-D-glucopyranosyl (1 --> 2)-beta-D-glucopyranoside (1) and Octane-1-en-3-ol-3-O-beta-D-glucopyranosyl (1 --> 2)-beta-D-glucopyranoside (2) respectively. Compounds 1 and 2 were isolated from this genus first and their anti-tumour activities were tested against two human tumour cell lines using MTT method.


Assuntos
Antineoplásicos Fitogênicos/isolamento & purificação , Dissacarídeos/isolamento & purificação , Medicamentos de Ervas Chinesas/isolamento & purificação , Gleiquênias/química , Plantas Medicinais/química , Antineoplásicos Fitogênicos/química , Antineoplásicos Fitogênicos/farmacologia , Dissacarídeos/química , Dissacarídeos/farmacologia , Medicamentos de Ervas Chinesas/química , Medicamentos de Ervas Chinesas/farmacologia , Células HeLa , Humanos , Estrutura Molecular , Paclitaxel/farmacologia
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa